Literature DB >> 8205622

A class switch control region at the 3' end of the immunoglobulin heavy chain locus.

M Cogné1, R Lansford, A Bottaro, J Zhang, J Gorman, F Young, H L Cheng, F W Alt.   

Abstract

We replaced the IgH 3' enhancer (3'EH) region with a neomycin resistance gene in ES cells and generated chimeric mice in which all mature lymphocytes were either heterozygous (3'EH+/-) or homozygous (3'EH-/-) for the mutation. In vitro activated 3'EH-/- B cells responded similarly to 3'EH+/- B cells with respect to proliferation and secretion of IgM and IgG1 but were specifically deficient in IgG2a, IgG2b, IgG3, and IgE secretion. These isotype deficiencies correlated with a deficiency in accumulation of transcripts from and class switching to affected CH genes. In vivo, chimeric mice containing only 3'EH-/- B cells were deficient in serum IgG2a and IgG3. We propose that the 3'EH-/- mutation disrupts the activity of a regulatory region that influences heavy chain class switching to several different CH genes that lie as far as 100 kb upstream of the mutation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8205622     DOI: 10.1016/0092-8674(94)90057-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  76 in total

1.  Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene.

Authors:  L Pan; S Sato; J P Frederick; X H Sun; Y Zhuang
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Polymorphism of the human alpha1 immunoglobulin gene 3' enhancer hs1,2 and its relation to gene expression.

Authors:  Y Denizot; E Pinaud; C Aupetit; C Le Morvan; E Magnoux; J C Aldigier; M Cogné
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

3.  T-bet regulates IgG class switching and pathogenic autoantibody production.

Authors:  Stanford L Peng; Susanne J Szabo; Laurie H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

4.  The HoxC4 homeodomain protein mediates activation of the immunoglobulin heavy chain 3' hs1,2 enhancer in human B cells. Relevance to class switch DNA recombination.

Authors:  Edmund C Kim; Christopher R Edmonston; Xiaoping Wu; András Schaffer; Paolo Casali
Journal:  J Biol Chem       Date:  2004-07-13       Impact factor: 5.157

Review 5.  The role of mechanistic factors in promoting chromosomal translocations found in lymphoid and other cancers.

Authors:  Yu Zhang; Monica Gostissa; Dominic G Hildebrand; Michael S Becker; Cristian Boboila; Roberto Chiarle; Susanna Lewis; Frederick W Alt
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

6.  Revision of T cell receptor {alpha} chain genes is required for normal T lymphocyte development.

Authors:  Ching-Yu Huang; Barry P Sleckman; Osami Kanagawa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

7.  Elucidation of IgH intronic enhancer functions via germ-line deletion.

Authors:  Thomas Perlot; Frederick W Alt; Craig H Bassing; Heikyung Suh; Eric Pinaud
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

8.  Proteasome activator PA200 is required for normal spermatogenesis.

Authors:  Bernard Khor; Andrea L Bredemeyer; Ching-Yu Huang; Isaiah R Turnbull; Ryan Evans; Leonard B Maggi; J Michael White; Laura M Walker; Kay Carnes; Rex A Hess; Barry P Sleckman
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

9.  Recombination and transcription of the endogenous Ig heavy chain locus is effected by the Ig heavy chain intronic enhancer core region in the absence of the matrix attachment regions.

Authors:  E Sakai; A Bottaro; L Davidson; B P Sleckman; F W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

10.  Transcription of a productively rearranged Ig VDJC alpha does not require the presence of HS4 in the IgH 3' regulatory region.

Authors:  Buyi Zhang; Adrienne Alaie-Petrillo; Maria Kon; Fubin Li; Laurel A Eckhardt
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.